Leveraging BTIG’s full resources, our Healthcare Investment Banking Group works alongside established and emerging, private and public healthcare companies to help them grow and capitalize on valuable market opportunities. With seasoned healthcare-focused banking professionals in Boston, New York and San Francisco, we collaborate with clients to execute transformative transactions.
Intellectual Capital, Individually Tailored Solutions, Unbiased Advisory Services and Unparalleled Support.
We deliver deep sector and transactional expertise across biotechnology, life science and diagnostic tools, medical technology and specialty pharmaceuticals. Regardless of the stage of their development, BTIG’s knowledgeable, senior team delivers operational and financial guidance to corporate clients across the healthcare spectrum. And, with our extensive industry relationships, we offer investor perspective and insights that help adjust and evolve corporate strategy.
Life Science Tools
MEET OUR BANKERS
See our Healthcare Research capabilities
Giving clients a full range of research capabilities for healthcare-related entitiesView More
August 6, 2020
BTIG Healthcare Investment Banking Team Adds Managing Director, Private Placement Specialist J. Rory Rohan
BTIG announced today that it has hired J. Rory Rohan as a Managing Director within its Healthcare Investment Banking division. Mr. Rohan will be based in the firm’s New York office, and will report to K.C. Stone, Managing Director and Head of Healthcare Investment Banking, at BTIG.
July 22, 2020
BTIG to Host Virtual Biotechnology Conference on August 10-11, 2020 – Firm Event to Feature Key Opinion Leaders and More Than 120 Corporate Management Teams
BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon Ha, PhD, Julian Harrison, Robert “Bert” Hazlett, and Thomas Shrader, PhD, CFA, as well as BTIG Healthcare Strategy and Franchise Sales Specialists Michael Karmiol, and Mikhail Keyserman, CMT, CFTe.
January 23, 2020
BTIG Adds Lin Yu, PhD, to Launch New Healthcare Royalty Monetization Business
BTIG announced today that Lin Yu, PhD, has joined the firm to launch a new Healthcare Royalty Monetization practice from within its Investment Banking unit. BTIG’s healthcare expertise makes the firm the ideal partner for its corporate and institutional investor clients exploring the purchase and sale of royalty streams.
January 9, 2020
BTIG to Host Targeted Therapeutics Conference on February 24, 2020 in New York - Industry Event to Feature Key Opinion Leaders and Corporate Management Teams
BTIG announced today that the “BTIG Targeted Therapeutics Conference” will take place on Monday, February 24, 2020 in New York. The conference will be hosted by BTIG Biotechnology Analysts Tim Chiang, Robert “Bert” Hazlett, Amanda Murphy, CFA, and Thomas Shrader, PhD, CFA, and BTIG Healthcare Strategy and Franchise Sales Specialists Mikhail Keyserman, CMT, CFTe, and Michael Karmiol.
OTHER BTIG PRODUCTS & SERVICES
Institutional Sales & Trading
With a broad global footprint, connects clients with experienced traders, and state-of-the-art technology that quickly responds and delivers results.
Outsource Trading & Prime Brokerage
Expert prime brokerage, outsource trading, capital introduction and electronic execution tools for emerging and established fund managers.
Research & Strategy
Contextualizing critical data points, BTIG helps clients connect the dots, focus on the big picture and elevate what matters most.